Medtronic to Acquire CathWorks for up to $585M

Medtronic to acquire CathWorks for up to $585M

The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery disease.

Medtronic to Acquire CathWorks for $585M - Orange County Business Journal

Medtronic today announced that it’s exercising its option to acquire Irvine-based medical device maker CathWorks at a valuation of $585 million. “We are thrilled to have CathWorks officially become part of the Medtronic family,” CathWorks Chief Executive Ramin Mousavi said in a statement. The two companies first entered an agreement in 2022 to co-promote CathWorks’ FFRangio System in the U.S., Europe and Japan. The deal is expected to close by t…

Medtronic exercises its option to acquire CathWorks

FFRangio system Medtronic has announced it will exercise its option to acquire CathWorks. The intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the CathWorks FFRangio system in the USA, Europe and Japan, where it is commercially available. The acquisition is valued at up to US$585 million with potential undisclosed earn-out payments post-acquisition. “Medtronic is thrilled to move forward with our…